How do activist investors change pharma company strategy?

Activist campaigns in pharma typically target underperforming portfolios, excessive overhead, or failed M&A integration. Starboard Value at Pfizer, Elliott Management at GSK, and Glenview Capital at CVS Health each triggered major strategic pivots within 12 months. Common demands include portfolio rationalization, R&D refocusing, board refreshment, and capital return acceleration.